Understanding early signs of neurodegeneration in patients with sleep behavior disorders
Official title: Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM sleep Behavior Disorder
Funded at University of Minnesota · NIH-10909338 · Data updated 2026-11-12
This study is looking at how REM sleep behavior disorder (RBD) might be linked to early signs of dementia in people who have started taking certain antidepressants, and it hopes to help identify warning signs like changes in color vision or mild memory issues that could mean a higher risk for conditions like Dementia with Lewy bodies or Parkinson's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $774,788 |
| NIH project number | 5R01AG075101-02 |
| Project ID | NIH-10909338 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults experiencing REM sleep behavior disorder, particularly those who have recently started serotonergic antidepressants.
✕Less likely to help
Patients who do not have REM sleep behavior disorder or are not on serotonergic medications may not benefit from this research.
What this research studies
This research investigates the connection between REM sleep behavior disorder (RBD) and early neurodegenerative changes, particularly in patients who have started serotonergic antidepressants. It aims to identify prodromal signs of dementia, such as impaired color vision and mild cognitive impairment, that may emerge in individuals with RBD. By analyzing these symptoms, the study seeks to better understand how RBD can indicate the risk of developing conditions like Dementia with Lewy bodies or Parkinson's disease. Patients will be monitored over time to assess the progression of symptoms and their relationship to neurodegeneration.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and intervention for patients at risk of developing neurodegenerative disorders.
How similar studies have gone: Previous research has indicated that early signs of neurodegeneration can be linked to sleep disorders, suggesting that this approach may yield valuable insights.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Howell, Michael J — University of Minnesota
- Study coordinator: Howell, Michael J
Related research
Other NIH-funded projects on the same topics.
-
Early brain changes in people whose dream‑enacting sleep began or worsened after SSRI antidepressants
This project looks for early signs of brain degeneration in people who started acting out their dreams after beginning serotonergic antidepressants like SSRIs.
-
Understanding how brain injuries affect sleep disorders in veterans
This study is looking at how brain injuries and PTSD might lead to sleep problems, specifically a condition called REM Sleep Behavior Disorder, in veterans, and it hopes to find out what causes these sleep issues and how they might relate to future health concerns.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Early PD signals in people with REM sleep behavior disorder
This study tests whether people with REM sleep behavior disorder show early signs of Parkinson’s disease before classic symptoms appear.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Multimodal prospective cohort of Parkinsonism
This project will try to track disease progression and improve diagnosis using imaging, clinical tests, and biological samples in people with parkinsonism, people with REM sleep behavior disorder, and healthy volunteers over five years.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.